• 1
    Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kimeyert S. Births: Final Data for 2006. Natl Vital Stat Rep 2009; 57: 125.
  • 2
    Green N, Damus K, Simpson J, Iams J, Reece E, Hobel C, Merkatz N, Greene M, Schwarz R. Research agenda for preterm birth: recommendations from the March of Dimes. Am J Obstet Gynecol 2005; 193: 626635.
  • 3
    Bardin C, Piuze G, Papageorgiou A. Outcome at 5 years of age of SGA and AGA infants born less than 28 weeks of gestation. Semin Perinatol 2004; 28: 288294.
  • 4
    Moster D, Lie R, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359: 262273.
  • 5
    Iams J, Goldenberg R, Mercer B, Moawad A, Meis P, Das A, Caritis S, Miodovnik M, Menard M, Thurnau G, Dombrowski M, Roberts J. The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 2001; 184: 652655.
  • 6
    Goldenberg R, Mercer B, Iams J, Moawad A, Meis P, Das A, McNellis D, Miodovnik M, Menard M, Caritis S, Thurnau G, Bottoms S. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Am J Obstet Gynecol 1997; 177: 812.
  • 7
    Mercer B, Goldenberg R, Das A, Moawad A, Iams J, Meis P, Copper R, Johnson F, Thom E, McNellis D, Miodovnik M, Menard M, Caritis S, Thurnau G, Bottoms S, Roberts J. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 1996; 174: 18851893.
  • 8
    Crane J, Van den Hof M, Armson B, Liston R. Transvaginal ultrasound in the prediction of preterm delivery: singleton and twin gestations. Obstet Gynecol 1997; 90: 357363.
  • 9
    Heath V, Southall T, Souka A, Elisseou A, Nicolaides K. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998; 12: 312317.
  • 10
    Iams J, Goldenberg R, Meis P, Mercer B, Moawad A, Das A, Thom E, McNellis D, Copper R, Johnson F, Roberts J. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996; 334: 567572.
  • 11
    Fonseca E, Celik E, Parra M, Singh M, Nicolaides K. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462469.
  • 12
    Meis P, Klebanoff M, Dombrowski M, Sibai B, Leindecker S, Moawad A, Northen A, Iams J, Varner M, Caritis S, O'Sullivan M, Miodovnik M, Leveno K, Conway D, Wapner R, Carpenter M, Mercer B, Ramin S, Thorp J, Peaceman A, Gabbe S. Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol 2005; 106: 557561.
  • 13
    ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician–gynecologists. Obstet Gynecol 2001; 98: 709716.
  • 14
    ACOG Committee Opinion number 419. Use of progesterone to reduce preterm birth. Obstet Gynecol 2008; 112: 963965.
  • 15
    NHS Maternity Statistics, England 2002–2003. Department of Health: London, UK, 2004; 24.
  • 16
    Clements K, Barfield W, Ayadi M, Wilber N. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics 2007; 119: 866874.
  • 17
    To M, Skentou C, Royston P, Yu C, Nicolaides K. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 2006; 27: 362367.
  • 18
    Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000; 38: 583637.
  • 19
    Odibo A, Stamilio D, Macones G, Polsky D. 17alpha-hydroxy-progesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis. Obstet Gynecol 2006; 108: 492499.
  • 20
    American Medical Association. [cited; based on transvaginal ultrasound, Medicaid reimbursement using Code 76817]. Available from:
  • 21
    Mosby's Drug Consult. Mosby Elsevier: Philadelphia, PA, 2007; 2041.
  • 22
    Nicholson W, Frick K, Powe N. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol 2000; 96: 95101.
  • 23
    Gilbert W, Nesbitt T, Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 2003; 102: 488492.
  • 24
    Waitzman N, Romano P, Scheffler R. Estimates of the economic costs of birth defects. Inquiry 1994; 31: 188205.
  • 25
    Russell R, Green N, Steiner C, Meikle S, Howse J, Poschman K, Dias T, Potetz L, Davidoff M, Damus K, Petrini J. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007; 120: e19.
  • 26
    Metropolis N, Ulam S. The Monte Carlo method. J Am Stat Assoc 1949; 44: 335341.
  • 27
    Marlow N, Wolke D, Bracewell M, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 919.
  • 28
    Cahill AG, Odibo AO, Caughey AB, Stamilio DM, Hassan SS, Macones GA, Romero R. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010; 202: 548.e18.
  • 29
    Sciscione AC. Maternal activity restriction and the prevention of preterm birth. Am J Obstet Gynecol 2010; 202: 231235.
  • 30
    Goldenberg R, Cliver S, Bronstein J, Cutter G, Andrews W, Mennemeyer S. Bed rest in pregnancy. Obstet Gynecol 1994; 84: 131136.
  • 31
    Hassan S, Romero R, Vidyadhari D, Fusey S, Baxter J, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; for the PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo controlled trial. Ultrasound Obstet Gynecol 2011; DOI: 10.1002/uog.9017.